Markets:

Overview

News

Currencies

International

Treasuries

Arcturus Therapeutics Holdings Inc (NQ:ARCT)

8.570 +0.270 (+3.25%)

Streaming Delayed Price Updated: 9:49 AM EDT, Apr 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcturus Therapeutics Holdings Inc

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023 ↗

May 11, 2023

Via Benzinga

Unity Software, Tapestry, CIRCOR International And Other Big Stocks Moving Higher On Thursday ↗

May 11, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Arcturus Therapeutics: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Why Arcturus Therapeutics Stock Is Soaring Today ↗

March 29, 2023

Investors liked what they heard in its Q4 update.

Via The Motley Fool

Arcturus Therapeutics's Return On Capital Employed Insights ↗

March 29, 2023

Via Benzinga

A Preview Of Arcturus Therapeutics's Earnings ↗

March 27, 2023

Via Benzinga

Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress

May 09, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 9, 2023

April 26, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Sprinklr, EVgo, Emergent BioSolutions And Other Big Stocks Moving Higher On Thursday ↗

March 30, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Arcturus Therapeutics's Return On Capital Employed Overview ↗

December 15, 2022

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

RH, Semtech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

March 30, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Semtech Corporation (NASDAQ: SMTC) shares dipped 12.7% to $28.00 in...

Via Benzinga

S&P 500 Up 1%; Bluebird Bio Shares Plummet ↗

March 29, 2023

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Wednesday. The Dow traded up 0.74% to 32,632.35 while the NASDAQ rose 1.51% to 11,893.07. The S&P 500, also...

Via Benzinga

Stocks Rise As Investors Bet On Bank Recovery ↗

March 29, 2023

Stocks are swinging higher today, as bond yields retreat and Wall Street bets that the worst of the regional banking crisis is in the rearview mirror.

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 29, 2023

Via Benzinga

Arcturus Therapeutics Ltd. (NASDAQ: ARCT) Leading the Way in Wednesday Trading Based on Percentage Gain

March 29, 2023

Via Investor Brand Network

Nasdaq Rises 1%; US Pending Home Sales Increase In February ↗

March 29, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded up 0.58% to 32,580.89 while the NASDAQ rose 1.09% to 11,843.85. The S&P...

Via Benzinga

Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 29, 2023

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.

Via Benzinga

Arcturus Therapeutics Stock Is Rising Wednesday: What's Going On? ↗

March 29, 2023

Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are trading higher Wednesday after the company reported strong fourth-quarter results and provided an update on pipeline progress.

Via Benzinga

US Stocks Open Higher, Dow Jumps Over 200 Points ↗

March 29, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.72% to 32,628.42 while the NASDAQ rose 1.33%...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 29, 2023

Via Benzinga

Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket ↗

March 29, 2023

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 29, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!

Via InvestorPlace

Cal-Maine Foods, Lululemon Athletica And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

March 29, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Arcturus Therapeutics Shares Are Moving Higher After Hours ↗

March 28, 2023

Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are booming in Tuesday's after-hours session after the company reported fourth-quarter results and provided an update on

Via Benzinga

Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress

March 28, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 28, 2023

March 07, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Attend Upcoming Investor Conferences

February 06, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis

January 31, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 19, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.